LCDActive
Platelet Rich Plasma
L38937
National Government Services, Inc. (J06)
Effective: February 10, 2022
Updated: December 31, 2025
See LCD L38937Policy Summary
Policy L38937 states that platelet-rich plasma (PRP) injections and applications used to manage musculoskeletal injuries or joint conditions are not covered. No covered indications, documentation requirements, or frequency allowances for PRP in these indications are provided in this policy.
Coverage Criteria Preview
Key requirements from the full policy
"All platelet-rich plasma (PRP) injections and/or applications for management of musculoskeletal injuries and/or joint conditions are not covered."
Sign up to see full coverage criteria, indications, and limitations.